Henry Meds Review 2026: Real Pricing, Fees, and the Eli Lilly Lawsuit

Disclosure: this article contains affiliate links. If you buy through them, we may earn a commission at no extra cost to you. Prices were checked in September 2026.

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Talk with a licensed healthcare provider before starting, stopping, or changing any prescription medication.

Quick answer: Henry Meds charges $297/month for compounded injectable semaglutide and $179 to $249/month for its other GLP-1 options, plus a non-refundable $30 consultation fee per prescription. As of September 2026, that’s no longer cheaper than paying cash for brand-name Zepbound ($299/month) or the Wegovy pill ($149/month) directly from the manufacturer. Henry also holds a BBB rating of F next to a 4.4 Trustpilot score, and it’s a defendant in an active Eli Lilly lawsuit.

What Does Henry Meds Actually Sell in 2026?

Henry Meds is the trade name for Adonis Health, Inc., prescribing through Colchis Medical Services PC (source). One thing several “review” sites still get wrong: Henry no longer sells injectable tirzepatide. Its own sitemap lists only an oral tirzepatide tablet, not the injectable version older articles still price at $449 or $549 a month (source). If a site quotes that injectable price, it’s reading from a stale cache.

Current lineup: compounded injectable semaglutide, compounded injectable liraglutide (daily), oral tirzepatide, oral semaglutide (tablet and sublingual drops), a new GLP-1 microdose option, phentermine, TRT for men, HRT for women, and ED treatment. Henry doesn’t name which compounding pharmacy fills its scripts; third-party sources mention Hallandale Pharmacy, unconfirmed.

Intake is a five-minute form, reviewed asynchronously or over video on Doxy.me by a nurse practitioner or physician assistant, not a physician; the CMO is Dr. Steven Peacock, DO. No blood work is required for GLP-1 programs. Henry states patients must be “at least 18 and no older than 70” for oral semaglutide. Shipping runs 7 to 10 business days after approval, so budget one to two weeks total.

How Much Does Henry Meds Cost in September 2026?

Below is the full Henry Meds price list, pulled directly from the company’s own pricing page, last updated December 3, 2025 (source).

Two flags before you check out. Henry charges a $30 medical consultation fee for every provider evaluation that results in a prescription, non-refundable once written: “Henry Meds collects a medical consultation fee of $30.00 for each provider evaluation that results in a prescription” (source). Also, Henry’s own pricing table contains a typo worth noting as a quality signal: the “Semaglutide Oral (3-Month Supply)” line describes “compounded orally dissolving tirzepatide tablets,” and elsewhere a “3-Month Supply” section says “for 6 months.” Check your cart total carefully.

The terms that generate the most complaints rarely make it into a headline:

• Every shipped prescription is a final sale the moment it ships.
• You get a 48-hour window to report damage, and one free reshipment per 90 days.
• Plans auto-renew: 3 to 7 days’ notice for monthly plans, 15 to 45 days for multi-month plans (source).
• Disputes go to mandatory arbitration; you waive class-action rights unless you opt out within 30 days.
• Henry does not accept insurance.

Henry Meds vs. Buying Brand-Name GLP-1s Directly: Who Wins on Price?

This is the comparison most reviews skip, and it changes the whole pitch for compounded semaglutide in 2026. Henry’s compounded semaglutide injection runs $297/month. Eli Lilly now sells brand-name Zepbound to cash-pay patients starting at $299/month through LillyDirect, and Novo Nordisk sells the Wegovy pill for $149/month through NovoCare.

Henry’s flagship injectable at $297 now sits essentially tied with brand-name Zepbound at $299, and well above the Wegovy pill at $149. Even Henry’s cheapest oral tier, $179 to $249, still costs more than a real, FDA-approved Wegovy pill from the manufacturer. The price gap that made compounded GLP-1s attractive in 2023 and 2024 has largely closed. One caveat: LillyDirect’s $299-$449 pricing only holds if you refill within 45 days; miss that window and it jumps to $499-$699. For a fuller side-by-side, see our Ro vs. Henry Meds comparison and our roundup of GLP-1 telehealth providers. If brand-name is your actual goal, start with how to get Ozempic for weight loss instead.

Is Compounded Semaglutide Even Legal Right Now?

Yes, for now, though the ground has shifted twice in 2026. The FDA declared the tirzepatide shortage resolved on December 19, 2024, and the semaglutide shortage resolved on February 21, 2025 (source), which legally ends the exemption that let compounders mass-produce copies. Compounders sued to keep operating; on August 27, 2026, the Fifth Circuit upheld both shortage determinations, ruling that “any error by the FDA in not proceeding through the APA’s notice and comment procedures was harmless” (tirzepatide ruling, semaglutide ruling). Compounders lost.

What still lets Henry operate is a narrower carve-out: “personalized dosing.” Under FDA policy updated April 1, 2026, a compounded drug counts as “essentially a copy” if it shares the active ingredient, a “same, similar or an easily substitutable strength,” and the same route of administration as the approved product, unless “a prescriber determines and documents the compounded drug product contains a change that produces a significant difference” for that patient (source).

The next shift may already be coming. On April 30, 2026, the FDA proposed removing semaglutide, tirzepatide, and liraglutide from the 503B bulk drug list (Federal Register, 91 FR 23431, Docket FDA-2018-N-3240) (source), with comments extended to July 30, 2026. As of this writing (September 6, 2026), it is still a proposal, not a final rule. Note the third drug on that list: liraglutide, exactly what Henry now pushes customers toward since dropping injectable tirzepatide. If finalized, one of Henry’s own core products goes with it. More background: the shortage court battle drugmakers just won and what peptides are and how they’re regulated.

What Do Henry Meds Reviews Actually Say?

Henry holds a 4.4 out of 5 across 12,524 Trustpilot reviews, 84% five-star, 7% one-star (source). That’s a paid Trustpilot profile Henry actively invites reviews on, which skews positive.

Set that beside the BBB file almost no review puts in the same paragraph: not accredited, an F rating, 233 complaints in three years (75 closed in the last 12 months, 27 the company never answered), and a 1.05/5 customer score across 37 reviews (source). BBB currently ranks above Henry’s own site for “henry meds review.” Complaint breakdown: 93 product issues, 61 service/repair, 24 billing, 21 sales/advertising, 18 customer service.

The recurring patterns: getting charged after canceling (or being unable to cancel), the 12-month commitment where a dose increase adds roughly $100/month, paying without receiving medication, support going quiet during 2026 escalations, doubts the oral formulations work, and shipments arriving warm despite FDA guidance to discard GLP-1 vials 28 days after first use, awkward given Henry ships three months of product in one box (source). On the plus side: fast scheduling, quick shipping, no insurance needed, and genuine 30-60 lb weight loss reported. One caution: starting around July 2026, templated “Henry Meds vs…” posts flooded r/henrymeds showing clear affiliate-spam patterns, so weigh that subreddit skeptically.

Is Henry Meds Facing a Lawsuit?

Yes, ongoing. Eli Lilly and Company v. Adonis Health, Inc., N.D. Cal., case 4:25-cv-03536, before Judge Jon S. Tigar. Lilly alleges Henry sold a “standard treatment plan [where] each patient will receive the same pre-made dosage of tirzepatide, over the same amount of time, regardless of any patient’s individualized circumstances,” while marketing it as “personalized” (source).

Henry’s motion to dismiss was filed September 24, 2025 and split the difference: the court dismissed the “safe and effective” claim but let the “personalized” claim proceed, finding Lilly “adequately alleges falsity.” No verdict, no injunction, as of this writing, but the case is active. This sits inside a wider crackdown: Novo Nordisk cut Hims & Hers off from Wegovy in June 2025, then announced 132 lawsuits across 40 states and 44 permanent injunctions by August 2025. The FDA sent warning letters to 50-plus companies by September 16, 2025, and 30 more by March 3, 2026, citing “claims implying sameness with FDA-approved products” (source). Henry isn’t named on that specific list, though the FDA hasn’t published every company it has contacted, so that’s not a clean bill of health.

As of a May 31, 2026 count, FDA has logged 990 adverse event reports tied to compounded semaglutide and 730-plus for compounded tirzepatide, page last updated September 1, 2026 (source), and the agency notes this likely undercounts, since compounding pharmacies aren’t required to report. For more, read are weight loss shots safe.

Who Should NOT Use Henry Meds

Henry fits a narrow buyer: someone who specifically wants a compounded GLP-1, doesn’t need insurance, and accepts the arbitration and final-sale terms. It’s a poor fit for:

• Anyone chasing the lowest price. Henry’s $297/month injectable no longer beats brand-name Zepbound at $299 or the Wegovy pill at $149 bought direct. Run your own numbers first.
• Anyone who wants baseline labs before starting. Henry skips blood work for weight-loss programs. Everlywell’s at-home hormone and thyroid tests run $149-$249 with no appointment needed.
• Anyone who wants GLP-1 access bundled with real lab work at a flat fee. Joi + Blokes prescribes GLP-1s including Zepbound and liraglutide alongside hormone care, with “$0” membership fees and a full hormone panel at $149.
• Anyone whose real goal is broader metabolic data, not just a script. Hundred runs 100+ annual lab tests and a clinician-built 100-day protocol from $199/year, a different product (data and coaching, not a pharmacy) worth knowing about.
• Anyone in a state Henry doesn’t clearly serve. Henry publishes no state list; third-party estimates put coverage around 40 states plus DC, excluding at least Alabama, Alaska, Arkansas, Hawaii, Louisiana, Mississippi, South Carolina, Tennessee, and West Virginia (list appears incomplete). Confirm your own state during intake before paying.
• Anyone who can’t live with a 48-hour damage window or strict final-sale terms.

Bottom Line: Should You Sign Up for Henry Meds in September 2026?

Henry Meds is real, it ships, and plenty of people report genuine weight loss. But three things most reviews haven’t caught up to: Henry no longer sells injectable tirzepatide, its compounded semaglutide now costs more than brand-name Zepbound bought direct, and the company is defending an active lawsuit over the word “personalized.” Add an F from the BBB, a non-refundable $30 fee, and mandatory arbitration, and the honest move is to check the brand-direct price first, read the cancellation terms, and decide with your eyes open. If you still want to move forward: see current Henry Meds pricing and programs.

Frequently Asked Questions

Does Henry Meds accept insurance?

No. Every program is cash-pay; there’s no insurance billing at any step.

Is compounded semaglutide the same as Ozempic or Wegovy?

No. Compounded semaglutide isn’t FDA-approved, evaluated, or reviewed for safety, effectiveness, or quality the way brand-name Ozempic and Wegovy are. The FDA has also flagged that some compounded products use semaglutide sodium or acetate, salt forms it says are “different active ingredients than are used in the approved drugs,” with no lawful basis identified for their use in compounding.

How long until medication arrives after signing up?

Henry states shipping takes 7 to 10 business days after approval, so plan on one to two weeks total from sign-up to having it in hand.

What is the Eli Lilly lawsuit against Henry Meds about?

Lilly alleges Henry marketed a one-size-fits-all dosing plan as “personalized.” A judge dismissed the “safe and effective” part of the claim but let the “personalized” claim proceed. The case, Eli Lilly v. Adonis Health, Inc. (N.D. Cal., 4:25-cv-03536), hasn’t reached a verdict.

Is the $30 Henry Meds fee refundable?

No. Once an evaluation results in a prescription, the $30 fee is non-refundable, and Henry’s processing fee is deducted from any refund “regardless of whether a prescription was issued.”